Abstract

: The “Cardiorenal Syndrome (CRS) “includes a simultaneous heart-kidney dysfunction in such a way that damage in one organ subsequently leads to damage in another and vice versa. Although for the first time in a classification in 2008, two main groups called cardiorenal and reno-cardiac (based on the onset of the disease in each organ) were used for this term, but today there are five main classifications for it. Various factors take part in this syndrome pathophysiology, including endotoxemia, inflammatory processes, metabolic derangements, infections, imbalance in neurohormones secretion, venous congestion and immunological dysfunction. But the main cause of this syndrome' onset in many cases is over-activity of renal sympathetic nerves and subsequently increased interaction with the stimulated renin-angiotensin system (both classical and non-classical axes). Regarding this fact, today renal denervation is known as a useful therapeutic approach in solving the disorders of this syndrome, which its safety and efficacy have been proven in many experimental and clinical studies. Respecting the above information, the aim of this study is to investigate the therapeutic effects of renal denervation in solving CRS disorders in more details, relying on the results of experimental and human studies in this field. The effects of using renin angiotensin blockers and other treatment methods for this syndrome have also been mentioned.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call